Virus safety of human immunoglobulins: Efficient inactivation of hepatitis C and other human pathogenic viruses by the manufacturing procedure

This publication has 19 references indexed in Scilit:

• Genetic organization and diversity of the hepatitis C virus.
  Proceedings of the National Academy of Sciences, 1991
• Transmission of Human Immunodeficiency Virus Type 1 (HIV-1) by Exposure to Blood: Defining the Risk
  Annals of Internal Medicine, 1990
• Safety of Therapeutic Products Used for Hemophilia Patients
  JAMA, 1988
• Detection of human immunodeficiency virus and other retroviruses in cell culture supernatants by a reverse transcriptase microassay
  Journal of Virological Methods, 1988
• Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency
  The American Journal of Medicine, 1988
• A strategy for testing established human plasma protein manufacturing procedures for their ability to inactivate or eliminate human immunodeficiency virus
  Journal of Biological Standardization, 1987
• S‐Sulfonation: a Reversible Chemical Modification of Human Immunoglobulins Permitting Intravenous Application
  Vox Sanguinis, 1983
• Plasma derivatives and viral hepatitis
  Transfusion, 1982
• Non-A, Non-B Hepatitis in Chimpanzees and Marmosets
  The Journal of Infectious Diseases, 1981
• Preparation and Properties of Serum and Plasma Proteins. IV. A System for the Separation into Fractions of the Protein and Lipoprotein Components of Biological Tissues and Fluids^1a,b,c,d
  Journal of the American Chemical Society, 1946